These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36307053)

  • 1. Dopamine inhibits pyroptosis and attenuates secondary damage after spinal cord injury in female mice.
    Jiang W; He F; Ding G; Wu J
    Neurosci Lett; 2023 Jan; 792():136935. PubMed ID: 36307053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase 1 inhibition modulates pyroptosis to improve recovery after spinal cord injury.
    Jiang W; He F; Ding G; Wu J
    FASEB J; 2022 Jun; 36(6):e22294. PubMed ID: 35579890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR4 aggravates microglial pyroptosis by promoting DDX3X-mediated NLRP3 inflammasome activation via JAK2/STAT1 pathway after spinal cord injury.
    Wang J; Zhang F; Xu H; Yang H; Shao M; Xu S; Lyu F
    Clin Transl Med; 2022 Jun; 12(6):e894. PubMed ID: 35692100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topotecan Reduces Neuron Death after Spinal Cord Injury by Suppressing Caspase-1-Dependent Pyroptosis.
    Jiang W; He F; Ding G; Wu J
    Mol Neurobiol; 2022 Oct; 59(10):6033-6048. PubMed ID: 35851945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of the microglial Hv1 proton channel attenuates neuronal pyroptosis and inhibits inflammatory reaction after spinal cord injury.
    Li X; Yu Z; Zong W; Chen P; Li J; Wang M; Ding F; Xie M; Wang W; Luo X
    J Neuroinflammation; 2020 Sep; 17(1):263. PubMed ID: 32891159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1 Receptor Agonist A-68930 Inhibits NLRP3 Inflammasome Activation, Controls Inflammation, and Alleviates Histopathology in a Rat Model of Spinal Cord Injury.
    Jiang W; Huang Y; He F; Liu J; Li M; Sun T; Ren W; Hou J; Zhu L
    Spine (Phila Pa 1976); 2016 Mar; 41(6):E330-4. PubMed ID: 26966979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elamipretide reduces pyroptosis and improves functional recovery after spinal cord injury.
    Jiang W; He F; Ding G; Wu J
    CNS Neurosci Ther; 2023 Oct; 29(10):2843-2856. PubMed ID: 37081763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the "segment" of spinal cord injury on the activity of the nucleotide-binding domain-like receptor protein 3 inflammasome and response to hormonal therapy.
    Majidpoor J; Mortezaee K; Khezri Z; Fathi F; Zali A; Derakhshan HB; Bariki MG; Joghataie MT; Shirazi R; Moradi F
    Cell Biochem Funct; 2021 Mar; 39(2):267-276. PubMed ID: 32893892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice.
    Jiang W; Li M; He F; Zhou S; Zhu L
    J Neuroinflammation; 2017 Oct; 14(1):207. PubMed ID: 29070054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paeonol regulates NLRP3 inflammasomes and pyroptosis to alleviate spinal cord injury of rat.
    Zhao H; Wang X; Liu S; Zhang Q
    BMC Neurosci; 2022 Mar; 23(1):16. PubMed ID: 35303801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-κB signaling pathway and pyroptosis after secondary spinal cord injury.
    Liu Z; Yao X; Jiang W; Li W; Zhu S; Liao C; Zou L; Ding R; Chen J
    J Neuroinflammation; 2020 Mar; 17(1):90. PubMed ID: 32192500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin Protects against Spinal Cord Injury and Cell Pyroptosis via AMPK/NLRP3 Inflammasome Pathway.
    Yuan Y; Fan X; Guo Z; Zhou Z; Gao W
    Anal Cell Pathol (Amst); 2022; 2022():3634908. PubMed ID: 35387358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipocalin-2 Deficiency Diminishes Canonical NLRP3 Inflammasome Formation and IL-1β Production in the Subacute Phase of Spinal Cord Injury.
    Müller N; Scheld M; Voelz C; Gasterich N; Zhao W; Behrens V; Weiskirchen R; Baazm M; Clarner T; Beyer C; Sanadgol N; Zendedel A
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury.
    Jiang F; Xia M; Zhang Y; Chang J; Cao J; Zhang Z; Qian Z; Yang L
    Front Immunol; 2022; 13():993168. PubMed ID: 36238284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicles Derived from Epidural Fat-Mesenchymal Stem Cells Attenuate NLRP3 Inflammasome Activation and Improve Functional Recovery After Spinal Cord Injury.
    Huang JH; Fu CH; Xu Y; Yin XM; Cao Y; Lin FY
    Neurochem Res; 2020 Apr; 45(4):760-771. PubMed ID: 31953741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IL1R1 or CASP4 attenuates spinal cord injury through ameliorating NLRP3 inflammasome-induced pyroptosis.
    Wang C; Ma H; Zhang B; Hua T; Wang H; Wang L; Han L; Li Q; Wu W; Sun Y; Yang H; Lu X
    Front Immunol; 2022; 13():963582. PubMed ID: 35990672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin Attenuates Spinal Cord Injury in Mice by Activating the Nrf2/ARE Signaling Pathway to Inhibit the NLRP3 Inflammasome.
    Wang H; Wang H; Huang H; Qu Z; Ma D; Dang X; Dong Q
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCC950 Reduces Neuronal Apoptosis in Spinal Cord Injury in Mice.
    He N; Zheng X; He T; Shen G; Wang K; Hu J; Zheng M; Ding Y; Song X; Zhong J; Chen YY; Wang LL; Yueliang S
    CNS Neurol Disord Drug Targets; 2021 Oct; 20(3):298-308. PubMed ID: 33023460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celastrol inhibits microglial pyroptosis and attenuates inflammatory reaction in acute spinal cord injury rats.
    Dai W; Wang X; Teng H; Li C; Wang B; Wang J
    Int Immunopharmacol; 2019 Jan; 66():215-223. PubMed ID: 30472522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
    Wang S; Yuan YH; Chen NH; Wang HB
    Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.